The Pioneer and A Leader in Engineered Precision Biologics

Expanded Genetic Code Technology Platform

We incorporate synthetic amino acids into proteins within living cells. The result? Product candidates designed to overcome the inherent limitations of conventional conjugation approaches.

A Wide Array of Modalities

We are advancing enhanced antibody-drug conjugates, immuno-oncology conjugates and bispecific candidates as potential treatments for cancer.